Patents by Inventor Preben Mikael Nielsen
Preben Mikael Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11318251Abstract: A medication delivery device comprises an injection device having a reservoir comprising a medicament to be ejected, and a sensor arranged to detect an ejection of the medicament from the injection device, the sensor being arranged to output a signal comprising ejecting information, and a processor for collecting and storing the ejection information.Type: GrantFiled: June 25, 2019Date of Patent: May 3, 2022Assignee: Novo Nordisk A/SInventors: Thomas Dedenroth Miller, Christian Peter Enggaard, Preben Mikael Nielsen, Bodo von Muenchow
-
Patent number: 10835683Abstract: A drug delivery system comprises an indicator element and a sensor system. The indicator element is arranged to rotate relative to a reference component and corresponding to a reference axis and comprises a plurality of dipole magnets. The sensor system comprises a plurality of magnetometers arranged non-rotational relative to the reference component and adapted to determine continuous magnetic field values from the plurality of dipole magnets, as well as processor means configured to determine on the basis of measured values from the plurality of magnetometers a rotational position and/or a rotational movement of the indicator element.Type: GrantFiled: June 15, 2020Date of Patent: November 17, 2020Assignee: Novo Nordisk A/SInventors: Nikolaj Eusebius Jakobsen, Preben Mikael Nielsen, Nikolaj Frogner Krusell, Laurits Hoejgaard Olesen
-
Publication number: 20200306456Abstract: A drug delivery system comprises an indicator element and a sensor system. The indicator element is arranged to rotate relative to a reference component and corresponding to a reference axis and comprises a plurality of dipole magnets. The sensor system comprises a plurality of magnetometers arranged non-rotational relative to the reference component and adapted to determine continuous magnetic field values from the plurality of dipole magnets, as well as processor means configured to determine on the basis of measured values from the plurality of magnetometers a rotational position and/or a rotational movement of the indicator element.Type: ApplicationFiled: June 15, 2020Publication date: October 1, 2020Inventors: Nikolaj Eusebius Jakobsen, Preben Mikael Nielsen, Nikolaj Frogner Krusell, Laurits Hoejgaard Olesen
-
Patent number: 10695504Abstract: A drug delivery system comprises means to create a log of expelled dose amounts of drug. Stored dose amounts determined within a given time period are combined to a single combined dose amount. The given time period is initiated by a detected expelling event taking place (i) a given amount of time after a previous detected expelling event, or (ii) after a given detected action. By this arrangement it is possible to create a log corresponding to what a user considers to be a single dose, i.e. combining “split doses” to create a single log entry for a per se split dose.Type: GrantFiled: April 3, 2014Date of Patent: June 30, 2020Assignee: Novo Nordisk A/SInventors: Preben Mikael Nielsen, Nikolaj Frogner Krusell, Jens Christian Andersen, Nikolaj Eusebius Jakobsen
-
Patent number: 10682469Abstract: A drug delivery system comprises an indicator element and a sensor system. The indicator element is arranged to rotate relative to a reference component and corresponding to a reference axis and comprises a magnetic ring. The sensor system comprises a plurality of magnetometers arranged non-rotational relative to the reference component and adapted to determine continuous magnetic field values from the plurality of dipole magnets, as well as processor means configured to determine on the basis of measured values from the plurality of magnetometers a rotational position and/or a rotational movement of the indicator element.Type: GrantFiled: January 2, 2020Date of Patent: June 16, 2020Assignee: Novo Nordisk A/SInventors: Nikolaj Eusebius Jakobsen, Preben Mikael Nielsen, Nikolaj Frogner Krusell, Laurits Hoejgaard Olesen
-
Publication number: 20190321547Abstract: A medication delivery device comprises an injection device having a reservoir comprising a medicament to be ejected, and a sensor arranged to detect an ejection of the medicament from the injection device, the sensor being arranged to output a signal comprising ejecting information, and a processor for collecting and storing the ejection information.Type: ApplicationFiled: June 25, 2019Publication date: October 24, 2019Inventors: Thomas Dedenroth Miller, Christian Peter Enggaard, Preben Mikael Nielsen, Bodo von Muenchow
-
Patent number: 10384013Abstract: Add-on module (100) for logging the value of an expelled dose from a pen-type drug injector (200), comprising a magnetic sensor system comprising first and second sensor means (745/746) as well as a mechanical dose setting and expelling mechanism comprising a magnetic clutch element (240/740) which rotates during drug expelling. The system further comprises processor means configured to determine (i) on the basis of measured values from the first sensor means, a rotational position of the clutch element, (ii) on the basis of measured values from the second sensor means, a high-speed condition in which the rotational speed of the clutch element exceeds a given threshold level, and (iii) indicate an error state if the high-speed condition is detected.Type: GrantFiled: October 1, 2015Date of Patent: August 20, 2019Assignee: Novo Nordisk A/SInventors: Nikolaj Frogner Krusell, Preben Mikael Nielsen, Jens Christian Andersen
-
Patent number: 10213554Abstract: A medial assembly comprises a logging first unit adapted to be mounted on a drug delivery device second unit from a fully un-mounted to a fully mounted position along a path. The first unit comprises a switch operatable between an off- and an on-state when the first unit is mounted on the second unit, the switch being in the on-state when the first unit is mounted within a first distance from the fully mounted position, and in the off-state when the first unit is mounted outside the first distance from the fully mounted position, and a snap lock operatable from an initial state through an expanded state to a snap-in state when the first unit is mounted on the second unit, the snap lock being in the snap-in state when the first unit is mounted within a second distance from the fully mounted position, the second distance being shorter than the first distance. By this arrangement it is ensured that the switch will be in the on-state before the snap lock is in the snap-in state.Type: GrantFiled: February 25, 2016Date of Patent: February 26, 2019Assignee: Novo Nordisk A/SInventors: Jens Christian Andersen, Preben Mikael Nielsen, Nikolaj Eusebius Jakobsen, Nikolaj Frogner Krusell
-
Patent number: 10159797Abstract: An add-on logging device (100, 300) mounted to a drug delivery device is turned on when the cap is removed. After a given amount of time in inactivity the sensor means of the add-on device is turned off automatically to save energy. If the user takes a dose of drug this is not detected as the add-on device is only turned on when the cap is removed. According to the present invention a warning message is provided when the cap is re-mounted after the sensor means has been turned off automatically, the warning message indicating to a user that an expelled dose may not have been detected.Type: GrantFiled: June 4, 2015Date of Patent: December 25, 2018Assignee: Novo Nordisk A/SInventors: Jens Christian Andersen, Nikolaj Frogner Krusell, Preben Mikael Nielsen
-
Publication number: 20170182256Abstract: An add-on logging device (100, 300) mounted to a drug delivery device is turned on when the cap is removed. After a given amount of time in inactivity the sensor means of the add-on device is turned off automatically to save energy. If the user takes a dose of drug this is not detected as the add-on device is only turned on when the cap is removed. According to the present invention a warning message is provided when the cap is re-mounted after the sensor means has been turned off automatically, the warning message indicating to a user that an expelled dose may not have been detected.Type: ApplicationFiled: June 4, 2015Publication date: June 29, 2017Applicants: Novo Nordisk A/S, Novo Nordisk A/SInventors: Jens Christian Andersen, Nikolaj Frogner Krusell, Preben Mikael Nielsen
-
Publication number: 20160030679Abstract: A drug delivery system comprises means to create a log of expelled dose amounts of drug. Stored dose amounts determined within a given time period are combined to a single combined dose amount. The given time period is initiated by a detected expelling event taking place (i) a given amount of time after a previous detected expelling event, or (ii) after a given detected action. By this arrangement it is possible to create a log corresponding to what a user considers to be a single dose, i.e. combining “split doses” to create a single log entry for a per se split dose.Type: ApplicationFiled: April 3, 2014Publication date: February 4, 2016Inventors: Preben Mikael NIELSEN, Nikolaj Frogner KRUSELL
-
Patent number: 8771238Abstract: The present invention relates to an injection device comprising an optically-based sensor for determining the position or setting of a dose setting member arranged to set a dose to be injected from the injection device. In particular, the present invention relates to an injection device comprising a rotatably mounted member having a plurality of optically coded paths arranged on an outer surface thereof. The rotatably mounted member is operatively connected to the dose setting member and is adapted to rotate with the dose setting member.Type: GrantFiled: May 1, 2012Date of Patent: July 8, 2014Assignee: Novo Nordisk A/SInventors: Preben Mikael Nielsen, Bodo Von Munchow, Carsten Bitsch Pedersen, Per Molgaard Pedersen
-
Publication number: 20130123685Abstract: Medical injection advice adapted for operating in a dose setting mode and in a dose administration mode, comprising a dosing actuator (124) reversibly actuatable from a first state for operating the device in the dose setting mode to a second state for operating the device in the dose administration mode, a switch (130, 132) adapted to sense positional information associated with the dosing actuator, and a controller coupled to the switch arrangement, wherein electronic mode representation is configured to enter dose setting mode after a time delay following detecting the dosing actuator has moved away from said second state or detecting the dosing actuator has moved into said first state.Type: ApplicationFiled: June 3, 2010Publication date: May 16, 2013Applicant: Novo Nordisk A/SInventors: Soren Kragh Jespersen, Claus Valentin Buschardt, Kim Ejholm Hansen, Bo Kvolsbjerg, Bennie Peder Smiszek Pedersen, Claus Urup Gjødesen, Preben Mikael Nielsen
-
Publication number: 20120215162Abstract: The present invention relates to an injection device comprising an optically-based sensor for determining the position or setting of a dose setting member arranged to set a dose to be injected from the injection device. In particular, the present invention relates to an injection device comprising a rotatably mounted member having a plurality of optically coded paths arranged on an outer surface thereof. The rotatably mounted member is operatively connected to the dose setting member and is adapted to rotate with the dose setting member.Type: ApplicationFiled: May 1, 2012Publication date: August 23, 2012Applicant: Novo Nordisk A/SInventors: Preben Mikael NIELSEN, Bodo VON MUNCHOW, Carsten Bitsch PEDERSEN, Per Molgaard PEDERSEN
-
Patent number: 8197449Abstract: The present invention relates to an injection device comprising an optically-based sensor for determining the position or setting of a dose setting member arranged to set a dose to be injected from the injection device. In particular, the present invention relates to an injection device comprising a rotatably mounted member having a plurality of optically coded paths arranged on an outer surface thereof. The rotatably mounted member is operatively connected to the dose setting member and is adapted to rotate with the dose setting member.Type: GrantFiled: May 8, 2006Date of Patent: June 12, 2012Assignee: Novo Nordisk A/SInventors: Preben Mikael Nielsen, Bodo Von Munchow, Carsten Bitsch Pedersen, Per Moelgaard Pedersen
-
Patent number: 7614545Abstract: The invention relates to a marking of cartridges, carpules or any kind of package. The marking can be in an electronically readable form while being transparent. Hereby a marking with improved security for avoiding reading errors which ensures a mandatory visual inspection of content is obtained. The transparent conductor can be in form of a polymer, an ITO and the like. These transparent conductors are used in an improved marking technique, which further improves reading security. The invention may e.g. be used in connection with medication delivery devices for self-treatment of a disease, e.g. diabetes.Type: GrantFiled: September 19, 2005Date of Patent: November 10, 2009Assignee: Novo Nordisk A/SInventors: Lasse Wengel Christoffersen, Preben Mikael Nielsen, Bo Erik Lennart Berggren
-
Publication number: 20080287865Abstract: The present invention relates to an injection device comprising an optically-based sensor for determining the position or setting of a dose setting member arranged to set a dose to be injected from the injection device. In particular, the present invention relates to an injection device comprising a rotatably mounted member having a plurality of optically coded paths arranged on an outer surface thereof. The rotatably mounted member is operatively connected to the dose setting member and is adapted to rotate with the dose setting member.Type: ApplicationFiled: May 8, 2006Publication date: November 20, 2008Applicant: Novo Nordisk A/SInventors: Preben Mikael Nielsen, Bodo Von Munchow
-
Patent number: RE49438Abstract: An add-on logging device (100, 300) mounted to a drug delivery device is turned on when the cap is removed. After a given amount of time in inactivity the sensor means of the add-on device is turned off automatically to save energy. If the user takes a dose of drug this is not detected as the add-on device is only turned on when the cap is removed. According to the present invention a warning message is provided when the cap is re-mounted after the sensor means has been turned off automatically, the warning message indicating to a user that an expelled dose may not have been detected.Type: GrantFiled: December 18, 2020Date of Patent: February 28, 2023Assignee: Novo Nordisk A/SInventors: Jens Christian Andersen, Nikolaj Frogner Krusell, Preben Mikael Nielsen